Article info
PDFResearch ethics
Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?
- Zhiyong Zong, Department of Infectious Diseases, West China Hospital, Sichuan University, Chegdu 610041, China; zzon6681{at}mail.usgd.edu.au
Citation
Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?
Publication history
- Received July 21, 2006
- Revised March 12, 2007
- Accepted March 20, 2007
- First published March 3, 2008.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group Ltd & the Institute of Medical Ethics
Other content recommended for you
- The revised International Code of Medical Ethics: an exercise in international professional ethical self-regulation
- WHO guidance on ethics in outbreaks and the COVID-19 pandemic: a critical appraisal
- Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach
- Can one do good medical ethics without principles?
- Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?
- Principles of justice in health care rationing
- Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
- Ethical issues in funding research and development of drugs for neglected tropical diseases
- Op GRITROCK ethics; the way of things to come?
- Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration